Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study

Author:

Hong Eun-GyoungORCID,Min Kyung-WanORCID,Lim Jung SooORCID,Ahn Kyu-JeungORCID,Ahn Chul WooORCID,Yu Jae-MyungORCID,Kim Hye SoonORCID,Kim Hyun JinORCID,Kim WonORCID,Kim Dong HanORCID,Jang Hak ChulORCID

Funder

Sanofi Korea

Seoul National University

Publisher

Springer Science and Business Media LLC

Reference32 articles.

1. International Diabetes Federation (IDF). IDF diabetes atlas. 10th edition 2021. https://www.diabetesatlas.org/en/. Accessed Feb 13, 2024.

2. World Health Organization (WHO). Global report on diabetes. 2016. https://www.who.int/diabetes/global-report/en/. Accessed Feb 13, 2024.

3. World Health Organization (WHO). Diabetes fact sheet. 5 April 2023. https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed Feb 13, 2024.

4. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;2023(402):203–34.

5. Bae JH, Han KD, Ko SH, et al. Diabetes fact sheet in Korea, 2021. Diabetes Metab J. 2022;46:417–26.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3